Deutsche Bank Aktiengesellschaft »

Silverback Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $84k 15k 5.48
2022-03-31 $39k 11k 3.50
2021-12-31 $83k 13k 6.66
2021-09-30 $118k 12k 10.00
2021-06-30 $239k 7.7k 30.87
2021-03-31 $536k 12k 43.48
2020-12-31 $232k 5.0k 46.40